Pterygium is a noncancerous growth of the conjunctival tissue over the cornea. It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular motility, chronic inflammation and cosmetic concerns. Surgical removal is the treatment of choice, but recurrence of pterygium is a frequent problem. In this randomized controlled cauterization will be compared with fibrin glue for conjunctival autografting in primary pterygium surgery.
adults (older than 18 years of age)
both sexes
primary nasal pterygia ˃4 mm, which tends to increase, including patients with reduced visual acuity, chronic inflammation, cosmetic reasons
if the patients had a bilateral pterygium, only one eye will be operated
connective tissue disease
prior eye surgery
chronic use of topical drugs (anti-glaucoma drugs)
University of Split, School of Medicine
Lead sponsor
University Hospital of Split
Collaborator